283 related articles for article (PubMed ID: 32151270)
1. Hemispheric asymmetry in the human brain and in Parkinson's disease is linked to divergent epigenetic patterns in neurons.
Li P; Ensink E; Lang S; Marshall L; Schilthuis M; Lamp J; Vega I; Labrie V
Genome Biol; 2020 Mar; 21(1):61. PubMed ID: 32151270
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in Parkinson's disease.
Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
Xie A; Ensink E; Li P; Gordevičius J; Marshall LL; George S; Pospisilik JA; Aho VTE; Houser MC; Pereira PAB; Rudi K; Paulin L; Tansey MG; Auvinen P; Brundin P; Brundin L; Labrie V; Scheperjans F
Mov Disord; 2022 Aug; 37(8):1644-1653. PubMed ID: 35723531
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective.
Marshall LL; Killinger BA; Ensink E; Li P; Li KX; Cui W; Lubben N; Weiland M; Wang X; Gordevicius J; Coetzee GA; Ma J; Jovinge S; Labrie V
Nat Neurosci; 2020 Oct; 23(10):1203-1214. PubMed ID: 32807949
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain.
Toker L; Tran GT; Sundaresan J; Tysnes OB; Alves G; Haugarvoll K; Nido GS; Dölle C; Tzoulis C
Mol Neurodegener; 2021 May; 16(1):31. PubMed ID: 33947435
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.
Yazar V; Dawson VL; Dawson TM; Kang SU
J Parkinsons Dis; 2023; 13(2):145-164. PubMed ID: 36710687
[TBL] [Abstract][Full Text] [Related]
7. Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies.
Renani PG; Taheri F; Rostami D; Farahani N; Abdolkarimi H; Abdollahi E; Taghizadeh E; Gheibi Hayat SM
J Cell Physiol; 2019 Nov; 234(11):19307-19319. PubMed ID: 30968426
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
Fernández-Santiago R; Merkel A; Castellano G; Heath S; Raya Á; Tolosa E; Martí MJ; Consiglio A; Ezquerra M
Clin Epigenetics; 2019 Jul; 11(1):108. PubMed ID: 31337434
[TBL] [Abstract][Full Text] [Related]
9. Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease.
Paul KC; Binder AM; Horvath S; Kusters C; Yan Q; Rosario ID; Yu Y; Bronstein J; Ritz B
BMC Genomics; 2021 Sep; 22(1):696. PubMed ID: 34565328
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation in Parkinson's disease.
Labbé C; Lorenzo-Betancor O; Ross OA
Acta Neuropathol; 2016 Oct; 132(4):515-30. PubMed ID: 27358065
[TBL] [Abstract][Full Text] [Related]
11. Possible roles of epigenetics in stem cell therapy for Parkinson's disease.
Thompson C; Otero P; Srinageshwar B; Petersen RB; Dunbar GL; Rossignol J
Epigenomics; 2020 Apr; 12(7):647-656. PubMed ID: 32396465
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood.
Henderson-Smith A; Fisch KM; Hua J; Liu G; Ricciardelli E; Jepsen K; Huentelman M; Stalberg G; Edland SD; Scherzer CR; Dunckley T; Desplats P
Epigenetics; 2019 Apr; 14(4):365-382. PubMed ID: 30871403
[TBL] [Abstract][Full Text] [Related]
13. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
[TBL] [Abstract][Full Text] [Related]
14. Impacts of Chromatin States and Long-Range Genomic Segments on Aging and DNA Methylation.
Sun D; Yi SV
PLoS One; 2015; 10(6):e0128517. PubMed ID: 26091484
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
Jakubowski JL; Labrie V
J Parkinsons Dis; 2017; 7(1):1-12. PubMed ID: 27792016
[TBL] [Abstract][Full Text] [Related]
16. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U
Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140
[TBL] [Abstract][Full Text] [Related]
17. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
Klokkaris A; Migdalska-Richards A
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892355
[TBL] [Abstract][Full Text] [Related]
18. Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson's disease-associated genes.
Tarale P; Sivanesan S; Daiwile AP; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Kannan K
Arch Toxicol; 2017 Jul; 91(7):2629-2641. PubMed ID: 27913844
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.
Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JB
Mov Disord; 2014 Nov; 29(13):1606-14. PubMed ID: 24375821
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation levels of α-synuclein intron 1 in the aging brain.
de Boni L; Riedel L; Schmitt I; Kraus TFJ; Kaut O; Piston D; Akbarian S; Wüllner U
Neurobiol Aging; 2015 Dec; 36(12):3334.e7-3334.e11. PubMed ID: 26422361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
